Aimia (AIM) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
12 Nov, 2025Executive summary
Achieved first profit for equity holders in over three years, with significant growth in Adjusted EBITDA and cash flow from operations despite macroeconomic and geopolitical headwinds.
Progressed on a three-step strategy: reducing holding company costs, narrowing share price discount, and preparing for new capital allocation and investments.
Core holdings Bozzetto and Cortland demonstrated resilience and outperformed peers.
Share buybacks reduced outstanding shares by 8.9% since June 2024, with $3.3M invested in Q3.
Increased liquidity and operating cash flow, supported by significant tax refunds.
Financial highlights
Q3 2025 consolidated revenue was $126.4M, down 2.1% year-over-year; gross profit was $34.1M with a margin of 27.0%.
Adjusted EBITDA rose 35% to $20.3M; operating income increased 37% to $7.8M.
Net earnings reached $1.4M, reversing a $2.2M loss in Q3 2024.
SG&A expenses declined 11% to $26.3M year-over-year, including $0.8M in HoldCo savings.
Cash and cash equivalents at quarter-end were $106.5M, up from $70.5M at June 30, 2025.
Outlook and guidance
On track to achieve 2025 Adjusted EBITDA guidance of $88–$95M for Bozzetto and Cortland combined.
Holding company costs expected to be $9M for 2025, with $6.4M incurred year-to-date.
Focus remains on executing the three-step strategy and making new investments in undervalued, cash-generative businesses.
Company will continue to monitor global trade developments and their impact on core holdings.
Latest events from Aimia
- Sale yields CAD 265–271M for debt reduction, new investments, and tax loss utilization.AIM
M&A announcement27 Feb 2026 - Q2 2024 delivered higher adjusted EBITDA, strong liquidity, and active capital return initiatives.AIM
Q2 20241 Feb 2026 - Q3 2024 saw double-digit revenue and EBITDA growth, strategic alignment, and strong liquidity.AIM
Q3 202415 Jan 2026 - Strong Q4 and FY2024 growth, capital structure gains, and positive 2025 EBITDA outlook.AIM
Q4 202425 Dec 2025 - Q1 revenue and EBITDA surged on cost cuts, core growth, and a $53.8M issuer bid gain.AIM
Q1 202526 Nov 2025 - Revenue and adjusted EBITDA rose in Q2 2025, with cost targets lowered amid tariff headwinds.AIM
Q2 202523 Nov 2025